Invega Sustenna 150mg Injection
Marketer
Janssen Pharmaceuticals
Salt Composition
Paliperidone (150mg)
Overview Invega Sustenna 150mg Injection
Palliperidone palmitate 150mg injection treats schizophrenia (a debilitating mental illness causing hallucinations, delusions, and impaired thinking/behavior) and manic episodes. Administered by a healthcare provider, consistent daily dosing maintains therapeutic levels. Sudden cessation is unsafe and should only occur under medical supervision; immediately discontinue if neuroleptic malignant syndrome (NMS) – featuring fever, muscle stiffness, and altered mental state – develops. Common side effects include injection site reactions (pain, swelling, redness), involuntary eye movement (nystagmus), tremor, dizziness, and drowsiness. Avoid activities requiring alertness until effects are known. Increased diabetes risk necessitates regular glucose monitoring. Report unusual mood/behavior shifts, new or worsening depression, or suicidal ideation to your physician. A patient support program exists in India, managed by Tata 1mg; inquire with your doctor or call (1800-102-1618) for details.
Primary Ingredients of Invega Sustenna 150mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Invega Sustenna 150mg Injection
Psychotic disorders involving psychosis and mood elevation
Major Benefits of Invega Sustenna 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Invega Sustenna 150mg Injection:
- Abnormal involuntary movements
- Dizziness
- Injection site reactions (pain, swelling, redness)
- Nystagmus (involuntary eye movement)
- Sleepiness
- Tremors
How to use Invega Sustenna 150mg Injection:
Administering this medication requires a healthcare professional (doctor or nurse). Self-medication is strictly prohibited.
How Invega Sustenna 150mg Injection works:
Xeplion 150mg, an atypical antipsychotic medication, modifies neurotransmitter levels (dopamine and serotonin) to positively influence mood, cognition, and conduct.
SAFETY ADVICE
AlcoholUNSAFE
Combining Invega Sustenna 150mg Injection with alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Invega Sustenna 150mg Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. Your physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while using Invega Sustenna 150mg Injection is likely inadvisable. Preliminary research in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Palperone 150mg injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if experiencing these side effects.
KidneyCAUTION
Patients with impaired kidney function should receive Invega Sustenna 150mg Injection with close monitoring; dosage modification may be necessary. Consult your physician for guidance. Invega Sustenna 150mg Injection is contraindicated in individuals with end-stage renal disease.
LiverCAUTION
Patients with severe hepatic impairment should receive Invega Sustenna 150mg Injection cautiously, potentially requiring dosage modification. Consult your physician. Data regarding Invega Sustenna 150mg Injection use in such patients is limited; however, dosage alteration is not advised for those with mild to moderate liver dysfunction.
What if you forget to take Invega Sustenna 150mg Injection :
NA
Facts to Know About Invega Sustenna 150mg Injection
| Label | Value |
|---|---|
| Chemical Type | Benzisoxazole Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience (CNS) |
| Behavioral Class | Non-Traditional Antipsychotics |
3,018 People bought this recently